MARKSANS PHARMA
Smallcap | BSE
Sector
Index
Here's the live share price of Marksans Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.86₹ -6.20
As on Aug 17, 2026, 01:39 PM IST
Source: Dion Global
Marksans Pharma Price Performance
Today's LowToday's High
₹325.55₹345.70
₹326.80
52 Weeks' Low52 Weeks' High
₹156.00₹336.80
₹326.80
Open Price
₹336.65
Prev. Close
₹333.00
Volume
11,33,604
Source: Dion Global
Marksans Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Marksans Pharma | 21.07 | 20.35 | 59.64 | 85.71 | 80.07 | 42.63 | 34.88 |
| Sun Pharmaceutical Industries | -2.24 | -2.41 | 1.35 | 12.10 | 16.72 | 18.59 | 19.56 |
| Divi's Laboratories | 2.86 | 16.48 | 25.49 | 37.88 | 37.60 | 31.76 | 11.60 |
| Torrent Pharmaceuticals | -1.70 | -2.99 | 10.48 | 14.26 | 33.26 | 34.77 | 26.91 |
| Zydus Lifesciences | 2.91 | -0.58 | 13.49 | 26.12 | 16.33 | 20.47 | 16.65 |
| Cipla | -2.93 | -0.64 | -0.19 | 5.38 | -8.67 | 4.76 | 9.96 |
| Lupin | -5.82 | -10.81 | -2.26 | 0.09 | 12.85 | 25.92 | 18.10 |
| Dr. Reddy's Laboratories | 1.64 | -3.14 | -10.90 | -6.15 | -5.75 | 0.49 | 5.02 |
| Mankind Pharma | -1.76 | -5.91 | -4.31 | 15.09 | -2.99 | 9.63 | 10.96 |
| Laurus Labs | -3.77 | 14.80 | 34.77 | 76.24 | 106.27 | 66.04 | 20.98 |
| Aurobindo Pharma | -1.70 | 5.26 | 8.03 | 37.79 | 49.79 | 23.19 | 17.21 |
| Biocon | -4.51 | -5.53 | -4.52 | 7.98 | 12.74 | 16.90 | 2.26 |
| Glenmark Pharmaceuticals | 1.01 | 0.65 | -0.64 | 13.72 | 17.00 | 42.56 | 32.32 |
| Alkem Laboratories | -3.74 | -4.37 | -1.20 | -1.11 | 1.33 | 12.76 | 7.85 |
| Abbott India | -3.83 | -3.31 | -4.36 | 1.50 | -18.12 | 3.88 | 7.11 |
| Anthem Biosciences | 5.91 | 18.50 | 13.65 | 29.35 | 11.20 | 6.83 | 4.04 |
| Gland Pharma | 12.56 | 18.80 | 56.77 | 61.78 | 48.45 | 23.75 | -6.64 |
| Ipca Laboratories | 7.62 | -0.45 | 16.41 | 24.61 | 34.99 | 28.13 | 9.15 |
| Ajanta Pharma | 6.20 | 7.28 | 16.68 | 25.89 | 37.72 | 27.84 | 19.53 |
| GlaxoSmithKline Pharmaceuticals | 4.02 | 8.51 | 10.55 | 3.80 | -3.31 | 23.99 | 10.92 |
Source: Dion Global
Over the last one year, Marksans Pharma has gained 80.07% compared to peers like Sun Pharmaceutical Industries (16.72%), Divi's Laboratories (37.60%), Torrent Pharmaceuticals (33.26%). From a 5 year perspective, Marksans Pharma has outperformed peers relative to Sun Pharmaceutical Industries (19.56%) and Divi's Laboratories (11.60%).
Marksans Pharma Financials
Source: Dion Global
Marksans Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 299.86 | 305.54 |
| 10 | 284.34 | 290.98 |
| 20 | 270.04 | 278.81 |
| 50 | 264.25 | 261.37 |
| 100 | 229.31 | 240.19 |
| 200 | 204.79 | 222.28 |
Source: Dion Global
Marksans Pharma Share Holding Pattern
In the latest quarter, Marksans Pharma remained same as its previous close in promoter holding, while DII stake decreased to 6.19%, FII holding rose to 17.47%, and public shareholding moved down to 32.46% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Marksans Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 19,72,958 | 0.8 | 50.97 | |
| 14,29,953 | 0.55 | 36.94 | |
| 11,50,000 | 2.17 | 29.71 | |
| 4,68,564 | 0.26 | 12.11 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Marksans Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 14, 2026, 12:16 AM IST IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Aug 12, 2026, 06:02 AM IST IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Aug 12, 2026, 06:01 AM IST IST | Marksans Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Aug 12, 2026, 05:55 AM IST IST | Marksans Pharma - Result For The Quarter Ended June 30, 2026 |
| Aug 12, 2026, 05:49 AM IST IST | Marksans Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 12 August 2026 |
Source: Dion Global
About Marksans Pharma
Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH1992PLC066364 and registration number is 066364. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 1341.48 Cr. and Equity Capital is Rs. 45.32 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- Address11th Floor, Grandeur, Mumbai Maharashtra 400053
- Contact
Source: Dion Global
Management
- Mr. Mark SaldanhaChairman & Managing Director
- Mrs. Sandra SaldanhaWhole Time Director
- Mr. Varddhman V JainWhole Time Director
- Dr. Sunny SharmaNon Executive Director
- Mr. Srinivas MishraIndependent Director
- Mr. Digant Mahesh ParikhIndependent Director
- Mr. Abhinna Sundar MohantyIndependent Director
- Mrs. Shailaja VardhanIndependent Director
FAQs on Marksans Pharma Share Price
What is the share price of Marksans Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Marksans Pharma is ₹326.80 as on Aug 17, 2026.
What kind of stock is Marksans Pharma?
The Marksans Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Marksans Pharma?
The market cap of Marksans Pharma is ₹15,015.58 Cr as on Aug 17, 2026.
What are today's High and Low prices of Marksans Pharma?
Today’s highest and lowest price of Marksans Pharma are ₹345.70 and ₹325.55.
What are the 52 Week High and 52 Week Low of Marksans Pharma?
The 52-week high/low is the highest and lowest price at which Marksans Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Marksans Pharma is ₹336.80 and 52-week low of Marksans Pharma is ₹156.00 as on Aug 17, 2026.
How has the Marksans Pharma performed historically in terms of returns?
The Marksans Pharma has shown returns of -1.61% over the past day, 18.95% for the past month, 57.79% over 3 months, 77.97% over 1 year, 42.0% across 3 years, and 34.52% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Marksans Pharma?
P/E ratio of and PB ratio of Marksans Pharma are 29.06 and 4.97 on Aug 17, 2026. While the company gives a dividend yield of 0.27 per annum.
Source: Dion Global
Marksans Pharma News
✕